Formosa Optical Technology Co.,Ltd. (TPEX:5312)
Taiwan
· Delayed Price · Currency is TWD 97.30
+0.20 (0.21%)
Apr 29, 2026, 1:30 PM CST
TPEX:5312 Revenue
In the year 2025, Formosa Optical Technology had annual revenue of 4.13B TWD with 3.94% growth. Formosa Optical Technology had revenue of 1.13B in the quarter ending December 31, 2025, with 14.97% growth.
Revenue
4.13B
Revenue Growth
+3.94%
P/S Ratio
1.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.13B | 156.53M | 3.94% |
| Dec 31, 2024 | 3.97B | 108.21M | 2.80% |
| Dec 31, 2023 | 3.86B | 565.98M | 17.16% |
| Dec 31, 2022 | 3.30B | 384.55M | 13.20% |
| Dec 31, 2021 | 2.91B | -148.72M | -4.86% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pacific Hospital Supply | 2.41B |
| St.Shine Optical | 4.12B |
| SciVision Biotech | 886.62M |
| Medeon Biodesign | 419.43M |
| Bioteque | 2.14B |
| Bionime | 1.84B |
| Maxigen Biotech | 811.56M |
| Nang Kuang Pharmaceutical | 2.16B |